Gamal Abdul Hamid
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Gamal Abdul Hamid has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
N M Saeed
2 shared publications- Abdul Wahab Al-Nehmi1 shared publication
- Afrah Saleh Saad Saleh Rajeh1 shared publication
- Amen Bawazir
College of Medicine, Almaarefa University, Riyadh, Saudi Arabia
1 shared publication Ansovini R
Medical Researcher Freelancer and Inventor of Ansovini Technology, Italy
1 shared publicationCabianca L
Medical Laboratory Turin Italy Citta’, Della Salute
1 shared publication
Latest Publications
- Open Access
- 31 December 2025
- Published by University of Aden in Electronic Journal of University of Aden for Basic and Applied Sciences
- Vol. 6 (4) , 252-264
HEMATOLOGICAL AND BONE METABOLISM ABNORMALITIES IN CHILDREN AND ADOLESCENTS WITH Β-THALASSEMIA MAJOR
β-thalassemia major (TM) is a transfusion-dependent hemoglobinopathy characterized by ineffective erythropoiesis and progressive iron accumulation. Despite improvements in transfusion and chelation regimens, metabolic bone disease remains a common and debilitating complication in young patients. To evaluate hematological indices and biochemical markers of bone metabolism in children and adolescents (≤21 years) with β-thalassemia major attending the Pediatric Department at the National Oncology Center, Aden, during January–December 2022. A cross-sectional analytical study of 40 transfusion-dependent TM patients was performed. Patients underwent complete blood counts and biochemical testing including serum ferritin, 25-OH vitamin D, parathyroid hormone (PTH), calcium and phosphorus. Descriptive statistics and categorical distributions versus reference ranges were analyzed. The cohort demonstrated severe chronic anemia (mean Hb 6.72 ± 1.77 g/dL; mean Hct 21.7 ± 6.1%) with microcytosis (mean MCV 73.5 ± 6.54 fL) and marked anisocytosis (RDW-CV 21.61 ± 7.00%). Median leukocyte count was 10.8 ×10³/µL with 60% of patients exhibiting leukocytosis; mean platelet count was increased (463.47 ± 281.4 ×10³/µL). Iron overload was profound (mean serum ferritin 3718.9 ± 2453.8 ng/mL), with 92.5% of patients above the normal ferritin range and 77.5% classified as high or severe (≥2000 ng/mL). Vitamin D insufficiency/deficiency was highly prevalent (mean 25-OH vitamin D 23.85 ± 9.96 ng/mL; 47.5% deficient, 27.5% insufficient, 25% adequate). Biochemical evidence of disturbed mineral homeostasis included hypocalcemia in 55% of patients, low PTH in 40%, and hyperphosphatemia in 45%. Together, these findings indicate a strong association between iron overload, endocrine dysfunction, and impaired bone mineral metabolism. Children and adolescents with β-thalassemia major in this cohort exhibit severe anemia, overwhelming iron accumulation, high prevalence of vitamin D deficiency, and frequent disturbances in calcium-phosphate-PTH axis—factors that collectively predispose to metabolic bone disease. Early, integrated strategies—including vigilant iron management, routine endocrine assessment, vitamin D optimization, and targeted bone health monitoring—are essential to mitigate long-term skeletal morbidity in this population.
- 31 December 2025
- Published by University of Aden in Electronic Journal of University of Aden for Basic and Applied Sciences
- Vol. 6 (4) , 252-264
Open AccessHEMATOLOGICAL AND BONE METABOLISM ABNORMALITIES IN CHILDREN AND ADOLESCENTS WITH Β-THALASSEMIA MAJOR
β-thalassemia major (TM) is a transfusion-dependent hemoglobinopathy characterized by ineffective erythropoiesis and progressive iron accumulation. Despite improvements in transfusion and chelation regimens, metabolic bone disease remains a common and debilitating complication in young patients. To evaluate hematological indices and biochemical markers of bone metabolism in children and adolescents (≤21 years) with β-thalassemia major attending the Pediatric Department at the National Oncology Center, Aden, during January–December 2022. A cross-sectional analytical study of 40 transfusion-dependent TM patients was performed. Patients underwent complete blood counts and biochemical testing including serum ferritin, 25-OH vitamin D, parathyroid hormone (PTH), calcium and phosphorus. Descriptive statistics and categorical distributions versus reference ranges were analyzed. The cohort demonstrated severe chronic anemia (mean Hb 6.72 ± 1.77 g/dL; mean Hct 21.7 ± 6.1%) with microcytosis (mean MCV 73.5 ± 6.54 fL) and marked anisocytosis (RDW-CV 21.61 ± 7.00%). Median leukocyte count was 10.8 ×10³/µL with 60% of patients exhibiting leukocytosis; mean platelet count was increased (463.47 ± 281.4 ×10³/µL). Iron overload was profound (mean serum ferritin 3718.9 ± 2453.8 ng/mL), with 92.5% of patients above the normal ferritin range and 77.5% classified as high or severe (≥2000 ng/mL). Vitamin D insufficiency/deficiency was highly prevalent (mean 25-OH vitamin D 23.85 ± 9.96 ng/mL; 47.5% deficient, 27.5% insufficient, 25% adequate). Biochemical evidence of disturbed mineral homeostasis included hypocalcemia in 55% of patients, low PTH in 40%, and hyperphosphatemia in 45%. Together, these findings indicate a strong association between iron overload, endocrine dysfunction, and impaired bone mineral metabolism. Children and adolescents with β-thalassemia major in this cohort exhibit severe anemia, overwhelming iron accumulation, high prevalence of vitamin D deficiency, and frequent disturbances in calcium-phosphate-PTH axis—factors that collectively predispose to metabolic bone disease. Early, integrated strategies—including vigilant iron management, routine endocrine assessment, vitamin D optimization, and targeted bone health monitoring—are essential to mitigate long-term skeletal morbidity in this population.
- Open Access
- 16 April 2023
- Published by Naksh Solutions in International Journal of Advanced Research in Science, Communication and Technology
- p. 484-515
S.A.R.S. COV-2 Spike Protein Derivates – ACE LINK - Graphene and Wireless Communications Radiation : Epidemiological -Chemico Physical and Toxicological Aspects -Scientific Evidence and other Interesting Documents
Aim of this work is to search and analyze scientific literature involved in the effect played by wireless communication radiation in the S.A.R.S.-COV-2 spike protein derivates pathological process. This make possible to verify if it is necessary to be considered as a toxicological co-factor Various published evidence finded graphene impurity in vial some C.O.V.I.D.-19 vaccine ( P. Campra) or in vaccinated blood ( Giovannini et al ) . But It is relevant to deeply investigate this phenomena using scientific evidence and other interesting documents ( scientific? ) from independed researcher useful to generate hypotesys to be confirmed . Crucial also to verify the subpopulation distribution of pathological event in vaccinated like pericarditys or central nervous system thrombosys as well as the use of some technological tool like smartphone in the various age classes. This method make possible to generate hypotesys to be better verified. Related the profile of some toxicological aspect of some C.O.V.I.D. -19 vaccine and in specifc way to the rare effect like pericarditis or trombosys are reported in this work some relevant literature involved in the effect played by the SPIKE PROTEINS and its link on epithelial tissue ACE receptor , the Graphene ( if present ) and under some magnetic field or electrical condition. An experimental hypotesys is submitted to the reseacher in order to produce a global conclusion of toxicological interest In this work is used a neutral approch without pre-concept.
- 16 April 2023
- Published by Naksh Solutions in International Journal of Advanced Research in Science, Communication and Technology
- p. 484-515
Open AccessS.A.R.S. COV-2 Spike Protein Derivates – ACE LINK - Graphene and Wireless Communications Radiation : Epidemiological -Chemico Physical and Toxicological Aspects -Scientific Evidence and other Interesting Documents
Aim of this work is to search and analyze scientific literature involved in the effect played by wireless communication radiation in the S.A.R.S.-COV-2 spike protein derivates pathological process. This make possible to verify if it is necessary to be considered as a toxicological co-factor Various published evidence finded graphene impurity in vial some C.O.V.I.D.-19 vaccine ( P. Campra) or in vaccinated blood ( Giovannini et al ) . But It is relevant to deeply investigate this phenomena using scientific evidence and other interesting documents ( scientific? ) from independed researcher useful to generate hypotesys to be confirmed . Crucial also to verify the subpopulation distribution of pathological event in vaccinated like pericarditys or central nervous system thrombosys as well as the use of some technological tool like smartphone in the various age classes. This method make possible to generate hypotesys to be better verified. Related the profile of some toxicological aspect of some C.O.V.I.D. -19 vaccine and in specifc way to the rare effect like pericarditis or trombosys are reported in this work some relevant literature involved in the effect played by the SPIKE PROTEINS and its link on epithelial tissue ACE receptor , the Graphene ( if present ) and under some magnetic field or electrical condition. An experimental hypotesys is submitted to the reseacher in order to produce a global conclusion of toxicological interest In this work is used a neutral approch without pre-concept.
- Open Access
- 9 February 2022
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 192 (1) , 207
Parents’ perception regarding paediatrics outpatients’ phone clinics
- 9 February 2022
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 192 (1) , 207
Open AccessParents’ perception regarding paediatrics outpatients’ phone clinics
- Open Access
- 8 September 2021
- Published by IntechOpen
Epidemiology and Outcomes of Nasopharyngeal Carcinoma
Nasopharyngeal carcinoma (NPC) is a rare head and neck neoplasm worldwide. It is common among the southern Chinese with significant geographical variation with the highest incidence being in Southeast Asia up to 6.4/100,000 males and 2.4/100,000 females in these regions and the Epstein Barr virus (EBV) is associated closely with NPC. This disease has peculiarities in its etiopathogenesis, presentation, risk of nodal and distant metastasis, response to therapy and overall survival (OS) outcomes that stand out as compared to other head and neck cancer subsites. NPC is mainly treated by RT and is profoundly radiosensitive and radiotherapy treatment is the spine of treatment for all stages of NPC without far off metastases. Many advances in RT techniques and schedules are attempted to improve outcomes of the disease starting from intracavitary brachytherapy, intensity modulated RT to simultaneous modulated accelerated RT, all showing some promise with most significant benefit seen with addition of chemotherapy, especially in intermediate (Stage II) and advanced (Stage III, IVA, IVB) cases. At a time when modern radiation treatment like intensity-modulated radiotherapy (IMRT) are accomplishing great good local control, distant metastases are getting to be the transcendent design of treatment failure, particularly in patients with locally progressed illness. There are numerous results from clinical trials looking at combined radiation treatment (RT) and chemotherapy for NPC. Survival rates significantly differ between NPC patients according to stages of disease.
- 8 September 2021
- Published by IntechOpen
Open AccessEpidemiology and Outcomes of Nasopharyngeal Carcinoma
Nasopharyngeal carcinoma (NPC) is a rare head and neck neoplasm worldwide. It is common among the southern Chinese with significant geographical variation with the highest incidence being in Southeast Asia up to 6.4/100,000 males and 2.4/100,000 females in these regions and the Epstein Barr virus (EBV) is associated closely with NPC. This disease has peculiarities in its etiopathogenesis, presentation, risk of nodal and distant metastasis, response to therapy and overall survival (OS) outcomes that stand out as compared to other head and neck cancer subsites. NPC is mainly treated by RT and is profoundly radiosensitive and radiotherapy treatment is the spine of treatment for all stages of NPC without far off metastases. Many advances in RT techniques and schedules are attempted to improve outcomes of the disease starting from intracavitary brachytherapy, intensity modulated RT to simultaneous modulated accelerated RT, all showing some promise with most significant benefit seen with addition of chemotherapy, especially in intermediate (Stage II) and advanced (Stage III, IVA, IVB) cases. At a time when modern radiation treatment like intensity-modulated radiotherapy (IMRT) are accomplishing great good local control, distant metastases are getting to be the transcendent design of treatment failure, particularly in patients with locally progressed illness. There are numerous results from clinical trials looking at combined radiation treatment (RT) and chemotherapy for NPC. Survival rates significantly differ between NPC patients according to stages of disease.
- Open Access
- 4 December 2019
- Published by IntechOpen
Introductory Chapter: Advances in Hematologic Malignancies
Open access peer-reviewed chapter
- 4 December 2019
- Published by IntechOpen
Open AccessIntroductory Chapter: Advances in Hematologic Malignancies
Open access peer-reviewed chapter
- Open Access
- 20 February 2019
- Published by IntechOpen
Diagnosis and Classification of Myelodysplastic Syndrome
Myelodysplastic syndrome (MDS) is a clonal hematopoietic stem cell disorder characterized by morphological dysplastic changes in one or more of the major hematopoietic cell lines. MDS can present with varying degrees of single or multiple cytopenias including neutropenia, anemia and thrombocytopenia. Presentation of MDS can range from asymptomatic to life threatening. MDS diagnosis and classification present important challenges, particularly in the distinction from benign conditions. French-American-British (FAB) classification proposed a classification based on easily obtainable laboratory information and was recommended in early and as modified by guidelines of new classification of World Health Organization (WHO). The strategy of diagnostic laboratory in MDS depends on morphological changes and is based on existence of dysplastic changes in the peripheral blood and bone marrow including peripheral blood smear, bone marrow aspirate smear and bone marrow trephine biopsy. The correct morphological interpretation and the use of cytogenetics, immunophenotyping, immunohistochemistry and molecular analysis will give valuable information on diagnosis and prognosis.
- 20 February 2019
- Published by IntechOpen
Open AccessDiagnosis and Classification of Myelodysplastic Syndrome
Myelodysplastic syndrome (MDS) is a clonal hematopoietic stem cell disorder characterized by morphological dysplastic changes in one or more of the major hematopoietic cell lines. MDS can present with varying degrees of single or multiple cytopenias including neutropenia, anemia and thrombocytopenia. Presentation of MDS can range from asymptomatic to life threatening. MDS diagnosis and classification present important challenges, particularly in the distinction from benign conditions. French-American-British (FAB) classification proposed a classification based on easily obtainable laboratory information and was recommended in early and as modified by guidelines of new classification of World Health Organization (WHO). The strategy of diagnostic laboratory in MDS depends on morphological changes and is based on existence of dysplastic changes in the peripheral blood and bone marrow including peripheral blood smear, bone marrow aspirate smear and bone marrow trephine biopsy. The correct morphological interpretation and the use of cytogenetics, immunophenotyping, immunohistochemistry and molecular analysis will give valuable information on diagnosis and prognosis.
- Open Access
- 29 September 2018
- Published by Edinburgh University Library in International Journal of Biopharmaceutical Sciences
- Vol. 1 (2) , 1-6-6
Chronic Myeloid Leukemia in South Yemen
Chronic Myeloid Leukemia in South Yemen
- 29 September 2018
- Published by Edinburgh University Library in International Journal of Biopharmaceutical Sciences
- Vol. 1 (2) , 1-6-6
Open AccessChronic Myeloid Leukemia in South Yemen
Chronic Myeloid Leukemia in South Yemen
- Open Access
- 9 January 2017
- Published by MedCrave Group Kft. in Journal of Cancer Prevention & Current Research
- Vol. 7 (1) , 1-3
Tobacco and Betel Quid in Development of Oral Cancer
Oral cancer is a public health problem in many parts of the world, representing the sixth most common malignant neoplasm. Oral cancer epidemiologically registers over 300000 new cases of oral cancer annually; two thirds of these cases occur in developing countries. The incidence of oral cancers among men is highest in northern India, a few areas of central and Eastern Europe, and Latin America. In Asian countries the high incidence rates were reported from developing nations like India, Pakistan, Bangladesh and Taiwan. Oral cancers displayed the worst survival rates in Latin America, India and Yemen. Some countries share specific risk factors namely heavy tobacco smoking, alcohol consumption, chewing of betel-quid, gutka, Zarda, Kharra, snuff and Khat. In addition, other specific risk factors are viral infection (HPV), poor oral hygiene and high intake of charcoal-grilled red meat and mate. Recommendation: Urgent public health measures are needed to reduce the incidence and mortality of oral cancer.
- 9 January 2017
- Published by MedCrave Group Kft. in Journal of Cancer Prevention & Current Research
- Vol. 7 (1) , 1-3
Open AccessTobacco and Betel Quid in Development of Oral Cancer
Oral cancer is a public health problem in many parts of the world, representing the sixth most common malignant neoplasm. Oral cancer epidemiologically registers over 300000 new cases of oral cancer annually; two thirds of these cases occur in developing countries. The incidence of oral cancers among men is highest in northern India, a few areas of central and Eastern Europe, and Latin America. In Asian countries the high incidence rates were reported from developing nations like India, Pakistan, Bangladesh and Taiwan. Oral cancers displayed the worst survival rates in Latin America, India and Yemen. Some countries share specific risk factors namely heavy tobacco smoking, alcohol consumption, chewing of betel-quid, gutka, Zarda, Kharra, snuff and Khat. In addition, other specific risk factors are viral infection (HPV), poor oral hygiene and high intake of charcoal-grilled red meat and mate. Recommendation: Urgent public health measures are needed to reduce the incidence and mortality of oral cancer.
- 1 January 2012
- No. 11,p. 16-9
Colorectal carcinoma at Al-Gamhouria Teaching Hospital, Aden, Yemen.
Colorectal cancer is the first common cause of cancer in men and the fourth cause after breast, NHL and ovary in women in Aden. This study aims to retrospectively analyze the pattern of patients with colorectal cancer seen in Oncology Unit, at Al-Gamhouria Teaching Hospital from January to December 2008. All cases of colorectal cancer presented at oncology unit, Al-Gamhouria Teaching Hospital in Aden Yemen between January and December 2008 were reviewed and the data was analyzed to determine age, gender, residency, clinical presentation, histological types and staging of disease and treatment. A total of 50 cases were included in the study, 34 (68%) male and 16 (34%) were female. (M:F 2.1:1). The mean age at presentation was 48.8 years for females and 56.4 for males. Abdominal pain (70%) and bleeding per rectum (50%) were the main presenting complaints. The most common sites are rectum (34%), caecum and ascending colon (30%) and sigmoid in 18% of cases. 82% of tumors of colorectal region were adenocarcinomas, the majority of which (66%) were well to moderately differentiated adenocarcinoma. Stages at presentation were: stage I (12%), stage II (18%), stage III (52%) and stage IV (18%). There is an increased incidence of colorectal carcinoma. Bad outcome directly related to late detection of cancer and >70 % of cases in stages III and IV. There is need to increase awareness through public education about this malignancy and its management. Any adult with complaints of vague abdominal pain, blood or mucus in the stool or features of haemorrhoids which may herald the onset of colorectal cancer should be adequately investigated with digital rectal examination (DRE) and proctosigmoidoscopy and barium enema where appropriate.
- 1 January 2012
- No. 11,p. 16-9
Colorectal carcinoma at Al-Gamhouria Teaching Hospital, Aden, Yemen.
Colorectal cancer is the first common cause of cancer in men and the fourth cause after breast, NHL and ovary in women in Aden. This study aims to retrospectively analyze the pattern of patients with colorectal cancer seen in Oncology Unit, at Al-Gamhouria Teaching Hospital from January to December 2008. All cases of colorectal cancer presented at oncology unit, Al-Gamhouria Teaching Hospital in Aden Yemen between January and December 2008 were reviewed and the data was analyzed to determine age, gender, residency, clinical presentation, histological types and staging of disease and treatment. A total of 50 cases were included in the study, 34 (68%) male and 16 (34%) were female. (M:F 2.1:1). The mean age at presentation was 48.8 years for females and 56.4 for males. Abdominal pain (70%) and bleeding per rectum (50%) were the main presenting complaints. The most common sites are rectum (34%), caecum and ascending colon (30%) and sigmoid in 18% of cases. 82% of tumors of colorectal region were adenocarcinomas, the majority of which (66%) were well to moderately differentiated adenocarcinoma. Stages at presentation were: stage I (12%), stage II (18%), stage III (52%) and stage IV (18%). There is an increased incidence of colorectal carcinoma. Bad outcome directly related to late detection of cancer and >70 % of cases in stages III and IV. There is need to increase awareness through public education about this malignancy and its management. Any adult with complaints of vague abdominal pain, blood or mucus in the stool or features of haemorrhoids which may herald the onset of colorectal cancer should be adequately investigated with digital rectal examination (DRE) and proctosigmoidoscopy and barium enema where appropriate.
- 1 January 2012
- Published by LookUs Bilisim A.S. in Turkish Journal of Hematology
- Vol. 29 (4) , 342-347
The Pattern of Hematological Malignancies at Al-Gamhouria Teaching Hospital, Aden, Yemen, from 2008 to 2010
METHODS: Hematological malignancies diagnosed at Al-Gamhouria Teaching Hospital, Department of Hematology-Oncology from January 2008 to December 2010 based on available hematological laboratory methods and histological examination were retrospectively analyzed. Clinical diagnoses were based on history and physical examination. Complete blood count was performed in all patients, bone marrow aspiration was performed in leukemia and multiple myeloma patients, and histopathological examination was performed in cases of malignant lymphoma.\ud RESULTS: Malignant hematological disorders were diagnosed in 300 patients aged 18-80 years (mean age: 43.6 years) with a male: female ratio of 1.23: 1. Among the male patients the most common malignant disorder was non-Hodgkin’s lymphoma, followed by Hodgkin’s lymphoma and acute myeloid leukemia. Among the female patients the most common malignant disorder was non-Hodgkin’s lymphoma, followed by acute myeloid leukemia, and Hodgkin’s lymphoma. The study provides the frequencies for the main hematological disorders and present the different subtypes of the Hodgkin’s and non-Hodgkin’s lymphomas.\ud CONCLUSION: The most common hematological malignancies in male patients were Non-Hodgkin’s lymphomas followed by Hodgkin’s lymphoma and acute myeloid leukemia. Gender distribution showed male predominance with striking predominance in Hodgkin’s lymphomas (M: F Ratio of 1.9: 1)
- 1 January 2012
- Published by LookUs Bilisim A.S. in Turkish Journal of Hematology
- Vol. 29 (4) , 342-347
The Pattern of Hematological Malignancies at Al-Gamhouria Teaching Hospital, Aden, Yemen, from 2008 to 2010
METHODS: Hematological malignancies diagnosed at Al-Gamhouria Teaching Hospital, Department of Hematology-Oncology from January 2008 to December 2010 based on available hematological laboratory methods and histological examination were retrospectively analyzed. Clinical diagnoses were based on history and physical examination. Complete blood count was performed in all patients, bone marrow aspiration was performed in leukemia and multiple myeloma patients, and histopathological examination was performed in cases of malignant lymphoma.\ud RESULTS: Malignant hematological disorders were diagnosed in 300 patients aged 18-80 years (mean age: 43.6 years) with a male: female ratio of 1.23: 1. Among the male patients the most common malignant disorder was non-Hodgkin’s lymphoma, followed by Hodgkin’s lymphoma and acute myeloid leukemia. Among the female patients the most common malignant disorder was non-Hodgkin’s lymphoma, followed by acute myeloid leukemia, and Hodgkin’s lymphoma. The study provides the frequencies for the main hematological disorders and present the different subtypes of the Hodgkin’s and non-Hodgkin’s lymphomas.\ud CONCLUSION: The most common hematological malignancies in male patients were Non-Hodgkin’s lymphomas followed by Hodgkin’s lymphoma and acute myeloid leukemia. Gender distribution showed male predominance with striking predominance in Hodgkin’s lymphomas (M: F Ratio of 1.9: 1)